Health Monitor Malta: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Monitor Malta.

Press releases published on October 16, 2026

7 minutes ago

Integra LifeSciences to Highlight ENT and Instruments Portfolios and Sponsor New Clinical Research Presentations at AAO-HNSF 2026 Annual Meeting

Indeterminate GlobeNewswire

10 minutes ago

Propanc Biopharma’s Lead Asset PRP Reprograms Chemotherapy-Resistant Pancreatic Cancer Cells

Indeterminate GlobeNewswire

17 minutes ago

Aprea Therapeutics to Host Pre-ESMO Virtual Panel on the State of WEE1 Inhibition in Precision Oncology

Indeterminate GlobeNewswire

17 minutes ago

Once-Weekly TransCon® CNP (Navepegritide) Receives Positive CHMP Opinion for the Treatment of Achondroplasia in Children

Indeterminate GlobeNewswire

28 minutes ago

Biomerica Reports First Quarter Fiscal 2027 Financial Results

Indeterminate GlobeNewswire

42 minutes ago

Inspire Named Finalist in Two Categories at the 6th Annual Anthem Awards

Indeterminate GlobeNewswire

42 minutes ago

GrowthHit Pledges 1% of Profits to Pediatric Cancer Research Following Founder's Daughter's Cancer Battle

Indeterminate GlobeNewswire

an hour ago

Quantum-Si to Provide a Business Update and Report Third Quarter 2026 Financial Results on November 5, 2026

Indeterminate GlobeNewswire

an hour ago

Nanox AI Ltd. Enters into Distribution Agreement with Technologic s.r.l., an Affiliate of Tecnologie Avanzate, to Commercialize Nanox.AI Bone Solution in Italy

Indeterminate GlobeNewswire

an hour ago

hear.com Receives 2026 Global Recognition Award for Hearing Care Innovation

Indeterminate GlobeNewswire

an hour ago

NeOnc Reports Early Clinical Improvement in First Child Treated with NEO100 Under Compassionate Use in Abu Dhabi

Indeterminate GlobeNewswire

an hour ago

twiist™ Automated Insulin Delivery System is Now Cleared for Adults with Type 2 Diabetes

Indeterminate GlobeNewswire

an hour ago

BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

2 hours ago

OXB Appoints Joachim Kreuzburg as Independent Non-Executive Director

Indeterminate GlobeNewswire

2 hours ago

Libtayo® (cemiplimab) Recommended for EU Approval by the CHMP for Updated Dosing Regimen Across All Approved Cancer Types

Indeterminate GlobeNewswire

2 hours ago

Tango Therapeutics to Present Updated Vopimetostat + RAS(ON) Combination Data at European Society For Medical Oncology (ESMO) Congress 2026

Indeterminate GlobeNewswire

2 hours ago

Fractyl Health's Revita Meets Six-Month Co-Primary Endpoint in Ongoing REMAIN-1 Pivotal Study, With Highly Statistically Significant Reduction in Weight Regain After GLP-1 Discontinuation

Indeterminate GlobeNewswire

2 hours ago

Adial Pharmaceuticals Appoints David Rubenstein, M.D., Ph.D., as Chief Scientist to Advance its Colon-Targeted AhR Agonist, AT177, for Ulcerative Colitis

Indeterminate GlobeNewswire

2 hours ago

Tiziana Doses Last Patient in Phase 2 Trial of Intranasal Foralumab for Mild Alzheimer’s Disease

Indeterminate GlobeNewswire

6 hours ago

Senturi Pharma announces exclusive European distribution agreement for PERTZYE®

Indeterminate GlobeNewswire